Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)butyramide MeSH Supplementary Concept Data 2025


MeSH Supplementary
3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)butyramide
Unique ID
C475422
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C475422
Entry Term(s)
ylgucpd74
Pharm Action
Gamma Secretase Inhibitors and Modulators
Registry Numbers
0
Heading Mapped to
*Benzodiazepinones
Frequency
1
Note
a gamma-secretase inhibitor; structure in first source
Source
J Med Chem 2003 Jun 5;46(12):2275-8
Date of Entry
2003/07/09
Revision Date
2021/05/20
3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4-hydroxy-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo(e)(1,4)diazepin-3-yl)butyramide Preferred
page delivered in 0.005s